Adriane Delaney, APRN
Women's Health · Magnolia, ARNPI 1578923116
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $332 and has fallen 61.1% since, to $129 in 2025.
Across 50 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$158
- AbbVie$154
- Astellas Pharma US Inc$139
- Myovant Sciences Inc.$107
- Lupin Inc.$81
- Hologic Sales And Service, LLC$67
- plus $262 from 9 others
What the payments were for
- Food & beverage$968100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $158 |
| AbbVie | 7 | $154 |
| Astellas Pharma US Inc | 4 | $139 |
| Myovant Sciences Inc. | 5 | $107 |
| Lupin Inc. | 6 | $81 |
| Hologic Sales And Service, LLC | 4 | $67 |
| Organon | 5 | $61 |
| Shield Therapeutics Inc | 3 | $49 |
| Mayne Pharma Commercial LLC | 1 | $34 |
| Agile Therapeutics, Inc. | 2 | $31 |
| Cepheid | 1 | $26 |
| Pfizer | 1 | $18 |
| Avion Pharmaceuticals | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $13 |
| Smith+Nephew | 1 | $13 |
How this compares
$968 in reported general payments places this provider in the 70th percentile of 44 women's health providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 37 | $3,155 |
| Tri-SprintecNorgestimate-Ethinyl Estradiol | 12 | $244 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 12 | $229 |
Paid to pharmacies, not to this prescriber.
Other women's health in Magnolia
- Malory WatsonEl Dorado$28K
- Wendy BennettSherwood$4K
- Margaret HicksBenton$3K
- Brandi AlexanderJohnson$3K
- Amy WilsonLittle Rock$3K
- Becca AustinLittle Rock$2K
- Jeni WarriorLittle Rock$2K
- Laurie CorbittRogers$2K
- Lisa HarmonFayetteville$2K
- Taylor PepperEl Dorado$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.